Autoimmune thyroid disorders during anti-TNF alpha therapy: Coincidence, paradoxical event or marker of immunogenicity?-Reference-Cited by-同舟云学术

Autoimmune thyroid disorders during anti-TNF alpha therapy: Coincidence, paradoxical event or marker of immunogenicity?

Published:2014-07 Issue:4 Volume:81 Page:369-370
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Pascart Tristan,Ducoulombier Vincent,Roquette Diane,Perimenis Pierrette,Coquerelle Pascal,Maury Frédéric,Baudens Guy,Morel Gauthier,Deprez Xavier,Flipo René-Marc,Houvenagel Eric

Publisher

Elsevier BV

Subject

Rheumatology

Reference10 articles.

1. Subacute thyroiditis presenting as fever of unknown origin in a patient with rheumatoid arthritis under etanercept treatment;Vassilopoulos;J Clin Rheumatol,2010

2. Subacute thyroiditis in a patient with juvenile idiopathic arthritis undergoing etanercept treatment: a case report and review of the literature;Yasuji;Mod Rheumatol,2013

3. Graves’ disease in a patient with rheumatoid arthritis during treatment with anti-tumor necrosis factor-alpha;Van Lieshout;J Rheumatol,2008

4. Silent thyroiditis associated with etanercept in rheumatoid arthritis;Andrés;Ann Rheum Dis,2002

5. Developing of granulomatous thyroiditis during etanercept therapy;Cañas;Clin Rheumatol,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of thyroid disorders in ankylosing spondylitis patients on anti-tumor necrosis factor treatment;Arab Journal of Rheumatology;2024-01

2. Painful Granulomatous Hashimoto Thyroiditis Uncovered Systemic Histoplasmosis;International Journal of Surgical Pathology;2023-07-17

3. Reduction in experimental autoimmune thyroiditis by IgG Fc fragments bearing regRF epitopes;Immunologic Research;2022-11-07

4. New aspects in the pathogenesis and management of subacute thyroiditis;Reviews in Endocrine and Metabolic Disorders;2021-05-05

5. Subacute thyroiditis in a patient with psoriatic arthritis switched from secukinumab to adalimumab: a case report and literature review;Modern Rheumatology Case Reports;2020-07-31